Detection of complement activation using monoclonal antibodies against C3d. - Wikidata - awgldk - TriplyDB

Detection of complement activation using monoclonal antibodies against C3d.

Detection of complement activation using monoclonal antibodies against C3d.

http://www.wikidata.org/entity/Q36793448

about

Complement in Lupus Nephritis: New Perspectives Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus Electrostatic Steering Accelerates C3d:CR2 Association.Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation.Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.The Immune System and AMD In vivo assessment of protease dynamics in cutaneous wound healing by degradomics analysis of porcine wound exudates.Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).Annexin A2 Enhances Complement Activation by Inhibiting Factor H Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.Targeting mechanisms at sites of complement activation for imaging and therapy.Complement factor H in AMD: Bridging genetic associations and pathobiology.Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.Extracellular vesicles from KSHV-infected endothelial cells activate the complement system.Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma

P2860

Q26740491-206D64DB-B1CC-4E86-AF6F-4B7FF445BAED Q26796871-D79839F4-389E-47DA-881A-07A17AA98BCF Q33594349-30C668E7-E9C1-4A19-846F-02C687F35727 Q33652041-C4800ADE-20CC-49C2-BFF5-05B42A9B3A85 Q33722349-D50FE10E-21FD-4B5B-A585-7D60F48E9FE2 Q33874253-1257EAB3-AD0D-4A91-BE44-F4B271A03088 Q34003743-D43D4C5B-5F31-49F8-BF45-8DC79ED6B063 Q35148563-E4706531-EC3E-438B-AA2A-133CA15A7DDA Q35633511-48EBF2CD-CF85-46F8-8C2C-0C87E7E9D915 Q36049479-ED63E4FA-FE0E-4F39-9B96-4C731694583F Q36148940-AA2D8DCD-A680-4371-A0BC-FB9BD9F823C9 Q36495141-242517CF-1466-40D1-A368-C314C774C67A Q37017177-A279CF7B-30B2-40A4-8609-80B33B545879 Q37180522-9FC6603B-6E10-475D-8093-01AEAA710264 Q38738490-0E6EED00-16AB-4377-86C5-4CC9FB3B4158 Q39450682-AD7726E3-E867-4985-93FC-D5CAC4022951 Q43194836-1D94E4B2-D1ED-4CB9-BE58-688F678AB781 Q46022690-1D147381-73BB-4F81-A1CF-A7D3B0B8246A Q46433084-A0D60B75-EA89-4B3C-8624-844F63593530 Q47112418-FFC56D46-4BBC-4F75-8D1F-F88A8E7A7E58 Q47714757-5D9C888C-1412-4601-B9D8-828903203C84 Q49497379-5285C755-C587-47E5-A2D6-C9C3B6094CC0 Q57039780-9592F0EF-170C-4876-8500-AE504872632F

P2860

Detection of complement activation using monoclonal antibodies against C3d.

http://www.wikidata.org/entity/Q36793448

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Detection of complement activation using monoclonal antibodies against C3d.

@ast

Detection of complement activation using monoclonal antibodies against C3d.

@en

type

label

Detection of complement activation using monoclonal antibodies against C3d.

@ast

Detection of complement activation using monoclonal antibodies against C3d.

@en

prefLabel

Detection of complement activation using monoclonal antibodies against C3d.

@ast

Detection of complement activation using monoclonal antibodies against C3d.

@en

P1433

Q36793448-062C9AF1-BCAC-4E4A-9D76-DD5717B8C57D

P1476

Q36793448-5030ADB2-F442-445B-9452-C79FB84D5059

P2093

Q36793448-039290C9-125D-4D9D-A070-9040F087D627

Q36793448-041692E2-9CF8-48D1-8142-B65ED0C255E9

Q36793448-102EE3E9-0BED-4284-BD8E-4E963EF8876A

Q36793448-2D58A1C3-BF56-45C0-977C-58817C1E399D

Q36793448-352838B7-FA4D-42BC-B5CA-EF15FFCB9BAA

Q36793448-361B7F6E-51B9-4815-872B-1EB78BF0C96D

Q36793448-46F7E8D7-D131-4894-B62D-0F2AC4819ADE

Q36793448-50D32B25-59A5-4352-AF9E-A6B2CB4A4D90

Q36793448-569D43B0-C00E-42AD-B1C6-EEEE41B5E783

Q36793448-E76B48DB-5F60-4E50-B90B-F66DE4186624

P2860

Q36793448-03E647BB-4798-43CC-B84D-FDA955E246C2

Q36793448-060F2D7A-BE0C-46E5-8366-6A2224E3A00E

Q36793448-178B6CFB-F873-4462-B2F5-6FE613C7D92D

Q36793448-1DD38690-6F0A-40A3-95B6-4C8828AEA0C9

Q36793448-1F3286DA-8B1F-42F8-9E50-ACDE2795BC68

Q36793448-24B0229E-AFB4-42D0-BB1F-DD0F0B64A33D

Q36793448-26AB0339-FFE3-45EE-B51D-BAF460274FDF

Q36793448-2772FE9B-7C5D-401B-8CF8-246C39C14DD7

Q36793448-288C2EC2-0EBA-4747-8401-C0806D1E6C59

Q36793448-2D1A46BB-5CFE-4F0A-B797-22ABCF11635C

P304

Q36793448-D9A29C06-A08F-4760-9C90-ABE46573BEA3

P31

Q36793448-DC5FC617-D3E1-4BFE-B362-78800B9DE192

P356

Q36793448-99D319A4-EFFC-476F-B4BE-48B6178E2ECE

P407

Q36793448-791F1BE0-04E4-4E04-9759-5992BF003D07

P433

Q36793448-DB029D5D-2D77-4765-A0B7-A966727E5976

P478

Q36793448-F47F2930-21AC-4120-8D6E-A260E02C48C8

P50

Q36793448-7CF932C7-E863-4A1A-847A-E72D33D7B9AC

Q36793448-83D18734-BA4A-46A9-8549-E8E4F90B6DE2

P577

Q36793448-CBF83F20-E17C-47E3-9AB2-FB345299E05F

P698

Q36793448-51C99BBC-2C12-4CE5-83F1-65D560173A5A

P932

Q36793448-03C6B345-3E1D-4853-B8FB-960E4CC69C08

P356

P1433

Journal of Clinical Investigation

P1476

Detection of complement activation using monoclonal antibodies against C3d.

@en

P2093

Alex S Woodell

http://www.w3.org/2001/XMLSchema#string

Beth Coughlin

http://www.w3.org/2001/XMLSchema#string

Brandon Renner

http://www.w3.org/2001/XMLSchema#string

Bärbel Rohrer

http://www.w3.org/2001/XMLSchema#string

Dennis E Hourcade

http://www.w3.org/2001/XMLSchema#string

Heather Orth

http://www.w3.org/2001/XMLSchema#string

James M Kovacs

http://www.w3.org/2001/XMLSchema#string

Joshua M Thurman

http://www.w3.org/2001/XMLSchema#string

Liudmila Kulik

http://www.w3.org/2001/XMLSchema#string

Lynne M Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

Drusen complement components C3a and C5a promote choroidal neovascularization

Control of the amplification convertase of complement by the plasma protein beta1H

Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

A crystal structure of the complex between human complement receptor 2 and its ligand C3d

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

Complement. Second of two parts

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Structure of C3b reveals conformational changes that underlie complement activity

P304

2218-2230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI65861

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan P Hannan

Matthew C Pickering

P577

2013-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23619360

http://www.w3.org/2001/XMLSchema#string

P932

3635726

http://www.w3.org/2001/XMLSchema#string